Botulinum toxin injections can visibly reduce platysmal bands, the vertical cords that become more prominent in the neck with age and muscle activity. A systematic review of clinical studies found a response rate above 90% at two weeks, with most patients still showing improvement at three months. The treatment works by relaxing the platysma muscle itself rather than tightening skin, which marks a meaningful shift in how clinicians think about the aging neck. But results depend heavily on who gets treated, how injections are placed, and what expectations look like going in.
What Platysmal Bands Actually Are
The platysma is a broad, thin sheet of muscle that drapes from the chest and shoulders up across the neck and lower face. Unlike most muscles, it sits just beneath the skin rather than deep against bone, which is why its movements are so visible on the surface. Platysmal bands are the raised vertical cords you can see and feel when you clench your jaw or pull the corners of your mouth down hard. They run from roughly the collarbone up toward the chin, and they become more prominent with age.
For decades, the conventional wisdom held that these bands appeared because the skin and muscle were becoming lax and sagging. That assumption drove surgical approaches focused on tightening. But research has challenged this framing. One study demonstrated that platysmal bands are not caused by relaxation of the platysma and skin laxity but rather by the activity of the platysma muscle itself, with the skin simply following the muscle underneath.1PubMed. Platysma Bands: Is a Change Needed in the Surgical Paradigm? Ultrasound imaging has reinforced this, showing that both the anterior and posterior platysmal bands are related to muscle thickness during contraction.2PubMed. Sonoanatomy of the platysmal bands: What causes the platysmal band? In other words, platysmal bands are an activity problem, not a sagging problem. That distinction matters because it explains why a muscle-relaxing treatment like botulinum toxin can work so well here.
Who Is a Good Candidate
Not everyone with visible neck aging will benefit from Botox in the platysma. The treatment works best when the bands themselves are the primary cosmetic concern, meaning they are driven by muscle contraction rather than by loose skin, heavy jowling, or excess fat under the chin. An expert consensus identified the ideal candidate as someone with prominent platysmal banding and a blunted or obscured jawline, but with little or no excess skin laxity and minimal submental fat.3PubMed Central. Platysma Prominence: Review and Expert Analysis of Clinical Presentation, Burden, and Treatment Considerations
If you have significant skin draping or a heavy pad of fat beneath the chin, Botox alone is unlikely to give you a noticeably smoother neck. Those issues require different interventions, whether liposuction for fat, energy-based devices for mild skin tightening, or surgical lifting for more advanced laxity. Platysmal Botox is best understood as a treatment for the muscular component of neck aging specifically. When the bands are the dominant feature, the results can be striking. When they are one element in a mix of skin looseness, fat accumulation, and bony changes, the improvement from Botox will look incomplete.
A simple screening step that providers use during consultation: asking the patient to grimace or pull the mouth corners down forcefully. If prominent cords pop up along the neck during this contraction, those are the dynamic bands that respond to toxin. Static bands that are visible even at rest may still improve, but typically less dramatically.
How the Injections Are Placed
The standard approach involves injecting directly into the visible muscular bands. A commonly described protocol uses about two units of onabotulinumtoxinA per injection point, with five points spaced roughly two centimeters apart along each band, from just below the jawline down toward the collarbone. Treating both medial and lateral bands on both sides of the neck typically uses around 40 units total.4PubMed Central. Anatomical Proposal for Botulinum Neurotoxin Injection Targeting the Platysma Muscle for Treating Platysmal Band and Jawline Lifting: A Review The patient is asked to activate the muscle by pulling down hard on the mouth angles so the injector can see and palpate exactly where the bands are most prominent. Each injection goes into the belly of the cord itself.
A newer line of research has mapped where the motor nerve endings actually cluster within the platysma. It turns out that motor end-plates, the junctions where nerves tell the muscle to contract, are concentrated in the upper portion of the platysma, while the lower third is largely sensory. A study testing targeted injections based on this nerve map found that focusing on the upper zone produced a meaningful band reduction in over 90% of patients by four weeks, and the improvement held through twelve weeks. Because fewer injection points were needed, average toxin use dropped by about a third compared to protocols that treat the entire length of the muscle, and bruising rates fell to around 5%, with no cases of difficulty swallowing or lower-face weakness.5PubMed Central. Optimizing Botulinum Toxin Injections in the Platysma Muscle Based on Motor Nerve Distribution
A split-neck comparison, where one side of a patient’s neck received the nerve-guided technique and the other received conventional injections, found that both approaches produced identical improvement scores at two weeks. Clinician ratings and patient self-assessments showed no statistical difference between the two sides.6PubMed Central. Neural Distribution–Guided Botulinum Toxin Injection for Platysma muscle: A Split‐Neck Comparison With Conventional Technique The clinical takeaway is that the nerve-guided approach is not better at reducing bands per se, but it may achieve the same result with less toxin and fewer side effects.
How Well It Works
Across the available clinical evidence, platysmal Botox consistently produces visible improvement in most patients. A systematic review pooling data from studies of mild to moderate platysmal bands found a mean score improvement of 2.0 points on a standardized severity scale at about two weeks, with a response rate of roughly 94%. At three months, the mean improvement had decreased to 1.2 points but was still present in 86% of patients. Patient-reported outcomes showed that about 91% of treated subjects rated their appearance as improved.7Aesthetic Surgery Journal. Botulinum Toxin Treatment for Mild to Moderate Platysma Bands: A Systematic Review of Efficacy, Safety, and Injection Technique
The largest controlled trial to date, a randomized, double-blinded phase 3 study, compared onabotulinumtoxinA against placebo. By day 14, about a third of the treatment group achieved both investigator- and participant-rated scores at the minimal or mild level with at least a two-grade improvement from baseline, compared to under 2% with placebo. Looking at each rater independently, roughly 57% of treated participants reached the minimal or mild category on the investigator’s scale, and about 52% did so on the participant’s own assessment. Satisfaction scores, self-reported bother from neck band appearance, and psychosocial impact all improved significantly in the treatment group.8Journal of the American Academy of Dermatology. Improvement of platysma prominence with onabotulinumtoxinA: Safety and efficacy results from a randomized, double-blinded, placebo-controlled phase 3 trial
That phase 3 trial is particularly important because it used a placebo arm, which most earlier studies lacked. The steep difference between treatment and placebo confirms that the improvement is not simply a regression-to-the-mean effect or a product of patients feeling better after any injection. The psychosocial findings are also worth noting: people who are bothered by their platysmal bands often report that the bands make them look older or angrier than they feel, and the trial data suggest that treatment materially reduced that burden.
How Long Results Last
Like Botox in any location, the effect in the platysma is temporary. The systematic review data show that improvement is strongest at around two weeks and has partially faded by three months, though most patients are still noticeably better at that point.9Aesthetic Surgery Journal. Botulinum Toxin Treatment for Mild to Moderate Platysma Bands: A Systematic Review of Efficacy, Safety, and Injection Technique In practice, most providers recommend retreatment every three to four months to maintain results, which is broadly consistent with the timeline for other facial Botox treatments like forehead lines or crow’s feet.
Over time, some patients report that their bands seem less severe even when the toxin has fully worn off between sessions. The theory is that repeated cycles of relaxation may lead to some degree of muscle disuse atrophy, where the platysma fibers thin out slightly from months of reduced contraction. This is anecdotal and not rigorously studied in the neck, but it mirrors what long-term Botox users report in other facial muscles. Whether this means you could eventually space treatments further apart is an open question.
Side Effects and Safety
The neck is a higher-stakes area for Botox than the forehead or around the eyes, because the platysma lies close to structures involved in swallowing, speech, and head movement. The most discussed risk is difficulty swallowing, which can occur if the toxin diffuses from the platysma into the deeper muscles of the throat. Case reports have documented dysphagia and difficulty speaking after cosmetic neck injections, likely from unintended spread of the toxin causing impairment of nearby muscles.10PubMed Central. Dysphagia and Muscle Weakness Caused by Botulinum Toxin Poisoning after Cosmetic Injection: Three Case Reports and Clinical Warnings These complications are rare but serious, and they underline why dose and injection depth matter.
Among less severe side effects, the systematic review of mild to moderate cases found that complications occurred in about 15% of patients, but none required further intervention.11Aesthetic Surgery Journal. Botulinum Toxin Treatment for Mild to Moderate Platysma Bands: A Systematic Review of Efficacy, Safety, and Injection Technique Common minor complaints include bruising at the injection site, mild neck weakness, and a temporary feeling of tightness or difficulty projecting the voice loudly. These typically resolve on their own within a few weeks as the body adjusts or the toxin effect moderates.
The nerve-guided injection approach mentioned earlier addresses safety directly. By concentrating injections in the upper platysma where the motor end-plates sit, and avoiding the lower portion near the deeper swallowing muscles, the study that tested this method reported no cases of dysphagia or lower-face weakness, with bruising in just 5% of patients.12PubMed Central. Optimizing Botulinum Toxin Injections in the Platysma Muscle Based on Motor Nerve Distribution The principle is straightforward: inject only where the motor signals are, use the minimum effective dose, and stay superficial enough to avoid deeper structures.
The Nefertiti Lift
A related technique that extends beyond the bands themselves is the Nefertiti lift, named after the Egyptian queen known for her sharply defined jawline. This approach uses Botox along the lower jawline and upper neck to relax the downward pull of the platysma, which over time tugs the lower face downward and softens the jaw’s contour. By weakening that pull, the upward-acting muscles of the face gain a relative advantage, producing a subtle lifting and tightening effect along the jaw.
The technique was described in a series of 130 patients using doses up to 20 units of botulinum toxin along the jawline. Patient satisfaction was reported as extremely high, and the specificity of dosing and placement kept adverse effects low.13PubMed. The ‘Nefertiti lift’: a new technique for specific re-contouring of the jawline The Nefertiti lift is often performed alongside platysmal band injections since the same muscle is being treated, just at different locations and for a somewhat different cosmetic goal. Band treatment addresses the visible cords running down the neck; the Nefertiti lift addresses the jawline definition that the platysma’s downward pull erodes over time. Together, they can produce a more comprehensive neck and lower-face rejuvenation than either alone.
Micro-Botox for the Neck
Conventional platysmal injections place the toxin into or just under the muscle itself. Micro-Botox, sometimes called mesotoxin or intradermal toxin, takes a different approach: hundreds of tiny droplets of highly diluted botulinum toxin are injected into the skin or the very shallow layer just beneath it, using a fine 30- or 32-gauge needle. Each injection raises a tiny blanched spot at the surface. The goal is not to paralyze the muscle in the way a standard injection does, but to partially relax the superficial muscle fibers while also affecting the skin’s sweat glands and sebaceous activity.14PubMed. Microbotox of the Lower Face and Neck: Evolution of a Personal Technique and Its Clinical Effects
In the neck, this technique has been described as improving horizontal creases, reducing vertical banding, and creating better apposition of the platysma to the jawline, which sharpens the angle where the chin meets the neck. A roundtable of clinical experts noted that intradermal micro-doses in the neck improved platysmal banding, transverse neck lines, and overall skin smoothness simultaneously.15PubMed Central. Microtoxin for Improving Pore Size, Skin Laxity, Sebum Control, and Scars: A Roundtable on Integrating Intradermal Botulinum Toxin Type A Microdoses Into Clinical Practice Because the toxin stays near the skin surface and is used at very low concentrations, the risk of diffusing into deeper swallowing muscles is inherently lower. The trade-off is that the effect on deep, prominent bands may be milder than a conventional intramuscular injection, so micro-Botox tends to be better suited for patients with mild banding or as a complement to standard injections for someone who also wants smoother neck skin texture.
How Providers Grade Severity
If you go in for a consultation, your provider will likely assess your platysmal bands against a standardized scale. The most widely referenced is a validated five-point system that rates band severity from 0, meaning no relevant prominence, to 4, indicating very severe prominence. When this scale was tested among a panel of plastic surgeons and dermatologists, the agreement between different raters was classified as almost perfect, and the consistency of individual raters over time was similarly high.16PubMed. Validated assessment scale for platysmal bands A separate group developed and validated a similar five-point scale specifically for platysmal banding in the female neck, using three-dimensional photographs from over 100 patients of various ages and ethnicities.17Aesthetic Surgery Journal. Development and Validation of a Clinical Assessment Tool for Platysmal Banding in Cervicomental Aesthetics of the Female Neck
These scales matter for you as a patient in a couple of practical ways. First, they set a common language between you and your provider. When someone rates your bands as a 3 out of 4, that means something specific and reproducible, rather than a vague impression. Second, they help set realistic expectations. The phase 3 trial used a two-grade improvement threshold as a meaningful response. If you start at a 3, reaching a 1 would count as a strong result. If you start at a 2, a two-grade improvement would mean near-complete resolution. If you start at a 4, dropping to a 2 would be a good outcome, but your neck still would not look band-free. Understanding where you start on the scale makes it much easier to calibrate what “success” looks like for your particular anatomy.
Off-Label Status and the Regulatory Landscape
As of mid-2025, botulinum toxin for platysmal bands remains an off-label use in most markets. Botox (onabotulinumtoxinA) is FDA-approved for specific cosmetic indications like glabellar lines and crow’s feet, but the neck has not yet received formal approval, despite widespread clinical use. The phase 3 trial published in the Journal of the American Academy of Dermatology is the type of study typically required as part of a regulatory submission, so approval may be on the horizon, but it has not arrived yet.18Journal of the American Academy of Dermatology. Improvement of platysma prominence with onabotulinumtoxinA: Safety and efficacy results from a randomized, double-blinded, placebo-controlled phase 3 trial
Off-label does not mean unsafe or unproven. Physicians legally prescribe medications off-label all the time, and the evidence base for platysmal Botox is stronger than for many FDA-approved cosmetic treatments at the time they were approved. What off-label status does mean is that insurance will not cover it, that informed consent documents may look different than for approved uses, and that the marketing of Botox specifically for neck bands is restricted. If a provider is unwilling to discuss off-label status openly, that is a red flag about the practice, not about the treatment.
Several botulinum toxin formulations are used clinically for platysmal bands. The systematic review data included both onabotulinumtoxinA and abobotulinumtoxinA, and the dosing is not interchangeable between them since their unit potencies differ. If a provider quotes you a dose, make sure you know which product they are using, because 40 units of one formulation is not the same as 40 units of another.